Literature DB >> 9050959

Prevalence of multiple sclerosis in the province of Teruel, Spain.

P J Modrego Pardo1, M A Latorre, A López, J M Errea.   

Abstract

There have been few reports about the frequency of multiple sclerosis (MS) in Spain. We undertook a prevalence study in the province of Teruel, which is served by two hospitals as referral centres for a population of 143,680. We found a total of 46 patients who fulfilled Poser's criteria for clinically definite or probable MS with a prevalence rate of 32/100,000 [95% confidence interval (CI): 22.8-41.3]. The prevalence rates for males and females were 23.5 (95% CI: 12.3-34.7) and 40.6 (95% CI: 25.8-55.4) respectively. We found an incidence rate of 2.2/year per 100,000 in the last 5 years. The sex ratio (females/males) was 1.7. The mean age on prevalence day was 40.6 years (range: 15-76). The clinical course was relapsing-remitting in 82% of patients, progressive in 9% and secondary progressive in the other 9%. The mean EDSS score was 3.73 (range: 1-8.5). Our results confirm the hypothesis that Spain is an area at high risk for MS.

Entities:  

Mesh:

Year:  1997        PMID: 9050959     DOI: 10.1007/s004150050070

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  5 in total

1.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 2.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

3.  Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.

Authors:  Rainel Sánchez-de la Rosa; Laura García-Bujalance; José Meca-Lallana
Journal:  Health Econ Rev       Date:  2015-10-16

4.  Long-term epidemiology of multiple sclerosis in the Northern Seville District.

Authors:  Guillermo Izquierdo; Ana Venegas; Carmen Sanabria; Guillermo Navarro
Journal:  Acta Neurol Scand       Date:  2015-02-04       Impact factor: 3.209

5.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.